Although studies have shown that chemokines are pyrogenic when injected into the brain, there are no data indicating which cell types and receptors in the CNS are employed by chemokines such as CCL3 (synonym: MIP-1a) to induce fever in rats. We aimed to study, whether CCL3 induces fever when injected directly into the thermoregulatory center within the pre-optic area (POA). Moreover, we investigated whether CCL3 activates cells from POA microcultures resulting in intracellular Ca ++ mobilization and synthesis/release of TNF-a and IL-6. Microinjections of CCL3 into the POA induced a dose-dependent fever, which was accompanied by a decrease in tail skin temperature. In conclusion the present study shows for the first time that CCL-3 injected directly into the rat POA, evoked an integrated febrile response. In parallel this chemokine induces Ca ++ signaling in astrocytes and neurons via both CCR1 and CCR5 receptors when administered to POA microcultures without stimulating the synthesis of TNF-a and IL-6. It is a possibility that CCL3-induced fever may occur via CCR1 and CCR5 receptors stimulation of astrocytes and neurons from POA.
Introduction
The rostral hypothalamus, especially the pre-optic area of the anterior hypothalamus (POA), contains temperature-sensitive and -insensitive neurons that form synaptic networks to control thermoregulatory responses (Dinarello et al., 1988; Boulant, 2000) . Although it is well established that the febrile response is triggered and regulated on the level of the POA, it is not clear how the mediators peripherally synthesized reach the brain tissue and alter the properties of the thermoregulatory center (Blatteis, 2006; Roth et al., 2009 ).
The substances which can act on POA for evoking a febrile response are named pyrogens. Those can be divided in two categories: exogenous and endogenous. In general, most of exogenous pyrogens are components from bacteria, virus, fungi and parasites The endogenous pyrogens are thermo-labile proteins and lipid mediators and are produced/released by the stimulation with exogenous pyrogens or trauma, lesions or stress (for review see Zeisberger, 1999; Blatteis, 2006) .
Endogenous pyrogens include a number of the cytokines, corticotrophin releasing factor, endothelins and chemokines (Fabricio et al., 2005; Soares et al., 2008; Machado et al., 2007 , for review see Roth et al. (2006) ). Chemokines are a family of structurally related proteins (8-15 kDa) that play a pivotal role in inflammation, sharing the ability to induce migration and activation of specific subsets of leukocytes (Baggiolini et al., 1994; Pease and Williams, 2006) .
A role of the chemokines on the manifestation of a febrile response was first evidenced by the capacity of MIP-1 to induce fever in rabbits and rats (Davatelis et al., 1989; Miñano et al., 1990) . We have contributed to the comprehension of the role of different chemokines on fever induction and maintenance (Zampronio et al., 1994; Soares et al., 2006; Machado et al., 2007; Soares et al., 2008 Soares et al., , 2009 ).
We previously demonstrated that i.c.v. injection of CCL3 induces an integrated febrile response evidenced by the increase in core body temperature coinciding with tail skin vasoconstriction (Soares et al., 2006) . Nonetheless, there are no published data showing which cells of the CNS, namely within the POA, are directly responsive to CCL3 and thereby involved in the pyrogenic effects of this chemokine.
Recent studies have shown that chemokines and their receptors are located throughout the brain, but are not uniformly distributed. Among chemokines and their receptors that are arrayed disproportionately in glia and neurons are monocyte chemotactic protein-1/ (CCL2), fractalkine/(CX3CL1), interferon-gamma-inducible-protein-10/(CXCL10), RANTES/(CCL5) and CCL3. In the brain, they are found in the hypothalamus, nucleus accumbens, limbic system, hippocampus, thalamus, cortex, and cerebellum. The uneven distribution suggests that there may be functional roles for the chemokine ''system,'' comprised of chemokine ligands and their receptors (Adler and Rogers, 2005; Adler et al., 2006) .
It is known that CCL3 binds on CCR1 and CCR5 which are expressed on neurons, microglia and astrocytes within the CNS (Galasso et al., 1998; Bajetto et al., 1999; Eltayeb et al., 2007; Knerlich-Lukoschus et al., 2011) . Therefore it seems possible that CCL3, by binding on these receptors, activates POA cells and induces fever by either directly evoking thermo-effector responses via pathways descending from the POA or by stimulating the synthesis/ release of other endogenous pyrogens as secondary mediators, such as PGE2 (Nakamura, 2011) .
We thus aimed to investigate whether CCL3, when injected into the pre-optic area, induces an integrated febrile response. Moreover, we investigated if the chemokine CCL3 directly activates CCR1 and CCR5 cells from POA microcultures (neurons, microglia or astrocytes) resulting in Ca ++ mobilization and synthesis/release of putative endogenous pyrogens (TNF-a and IL-6).
Experimental procedure

Animals
The in vivo experiments were conducted on male Wistar rats weighing 180-200 g, housed individually at 24 ± 1°C under a 12:12 h light-dark cycle (lights on at 06:00 AM) with free access to food and tap water until the night before the experiment, when only water was made available. Each animal was used only once. Care and use of the animals were in full compliance with the Ethical Principles in Animal Research adopted by the Brazilian College of Animal Experimentation (COBEA) and Guide for the Care and Use of Laboratory Animals of the Institute for Laboratory Animal Research (National Research Council, 1996) , and the study was previously approved by the Animal Research Ethics Committee of the Faculty of Medicine Ribeirão Preto Campus, University of São Paulo (protocol number 08.1.1404.53.8).
Wistar rat pups of both sexes obtained from an in-house breeding colony were used for all in vitro experiments, with parent animals originating from Charles River WIGA (Sulzfeld, Germany). Animal care, breeding and experimental procedures have been conducted according to the guidelines approved by the Hessian Ethical Committee. Adult rats had free access to drinking water and standard lab chow; the pups were reared by their mothers in large M4-size cages. Room temperature was controlled at 24 ± 1°C and relative humidity at 50 percent, and artificial lights were on from 7:00 AM to 7:00 PM.
Implantation of the intrahypothalamic cannula
The rats were anaesthetized with a mixture of ketamine and xylazine (58 mg kg À1 and 20 mg kg À1 , respectively, intraperitoneal (i.p.) and stereotaxically, unilaterally implanted with a permanent 24-gauge stainless steel guide cannula (0.55 mm outer diameter, 15 mm long) into the AH/POA. The stereotaxic coordinates were: 0.6 mm lateral to the midline, 7.7 mm anterior to the interaural line, and 6.5 mm under the brain surface; and the incisor bar was lowered 3.0 mm below the horizontal zero, according to Paxinos and Watson (1997) . Cannulae were fixed to the skull with jeweller's screws embedded in dental acrylic cement. All procedures were conducted under aseptic conditions. Animals were treated with oxytetracycline hydrochloride (400 mg kg À1 , i.m.) and allowed to recover for 1 week prior to experimental use.
2.3. Intra-POA CCL3 injection and rectal or skin measurements temperature measurement
In the first series of experiments we aimed to determine the dose of CCL3, which was able to induce a febrile response in rats. For this purpose, CCL3 at doses of 1, 5, 25 and 50 pg or sterile saline was microinjected into the AH/POA, and the animals' rectal temperature was monitored by telethermometry for up to 6 h. Moreover, in order to verify the effect of intra AH/POA injection of CCL3 on the heat loss index (Romanovsky et al., 2002) , 25 pg of the chemokine was administered into that area and the rectal and tail skin temperatures were measured by telethermometry using a thermistor probe attached with adhesive tape to the lateral surface of the proximal segment of the tail (Figueiredo et al., 2010) .
The aseptically performed microinjections into the AH/POA took place between 10:00 and 11:00. For this purpose, a 30-gauge needle, connected to polyethylene (PE10) tubing, was used. The needle protruded 2 mm beyond the cannula tip and a 500 nl volume was injected slowly (over 1 min) with a 25 ll Hamilton syringe coupled to a microinfusion pump (KD Scientific, model KDS101, EUA). After injection, the needle remained in place for 30 s before it was withdrawn to prevent backflow of the injection fluid through the cannula.
The rectal temperature was measured in conscious and unrestrained rats for 1 min every 30 min for up to 6 h, by gently inserting, 4 cm into the rectum, a vaseline-coated thermistor probe (model 402 coupled to a model 46 telethermometer, Yellow Springs Instruments, Ohio, USA.), without removing the animals from their home cages.
Experimental measurements were conducted at the thermoneutral zone for rats (Gordon, 1990) , in a temperature-controlled room kept at 28 ± 1°C, following adaptation of the animals to this environment for at least 1 h. After this period, baseline temperatures were determined 4 times at 30 min intervals prior to any injection; only animals displaying mean basal rectal temperatures between 36.8°C and 37.2°C were selected. To minimize core temperature changes due to handling, animals were conditioned twice to this environment and procedure on the preceding day.
Histology
Each rat was microinjected into the POA (300 nl) with Evan's Blue (2.5%). Immediately after the dye microinjection, each rat was given a lethal dose of pentobarbital, perfused transcardially with 0.9% saline, followed by 4% paraformaldehyde. Each brain was removed, stored in the same fixative for 6 h, kept in 30% sucrose overnight, and cut at 40 lm on freezing microtome. From analysis of the histological material under light microscopy, the position of the cannulae and the respective perfusion sites were subsequently verified and ''mapped'' anatomically. Animals showing cannula misplacement or blockage upon injection, or abnormal weight gain patterns during the post-implantation period were excluded from the study.
Isolation and cultivation of POA primary cell cultures
Primary microcultures of the rat POA were established from topographically excised brain tissue of five to six day old Wistar rat pups. The animals were decapitated, the brains removed from the skull under aseptic conditions and transferred to 3 cm Petri dishes filled with cold, oxygenated GBSS (Gey's Balanced Salt Solution; Biotrend, Köln, Germany) containing 5% D-glucose (Sigma Aldrich, Munich, Germany). A thin slice (400 lm) containing the anterior commissure was cut with a vibratome, and the POA including tissue (Fig. 1) was dissected from the slice using fine eye scissors.
The isolated POA tissue was transferred into Petri dishes containing oxygenated HBSS (Hanks Balanced Salt Solution without Ca 2+ and Mg
2+
; Biochrom, Berlin, Germany) supplemented with 20 mM HEPES (Sigma Aldrich) pH 7.4. The supernatant was removed, and POA fragments were treated with 2 ml dispase (1 U/ ml; Roche Diagnostics, Mannheim, Germany) in oxygenated HBSS with 20 mM HEPES, pH 7.4, for 30 min at 37°C. After incubation the tissue was washed with 1 mM EDTA (Sigma Aldrich) in HBSS to inactivate the enzyme. After three washes with 3 ml complete medium consisting of Neurobasal medium A supplemented with 2% B 27 (Invitrogen, Karlsruhe, Germany), penicillin (100 U/ml)/ streptomycin (0.1 mg/ml) and 2 mM L-glutamine (Biochrom), 2 ml complete medium were added to each tube and the tissue was dissociated by repeated trituration with a 1 ml eppendorf pipette. The dissociated POA cells were plated onto pre-warmed, poly-L-lysine (1 mg/ml H 2 O; Sigma Aldrich) coated CELLocate Ò glass coverslips (Eppendorf, Hamburg, Germany) forming the bottom of a reusable Flexiperm-micro-12 well (6 mm diameter; Greiner Bio-One GmbH, Solingen, Germany) to ensure sufficient cell density despite limited absolute cell number, and cultured in a humidified atmosphere of 5% CO2 and 95% air at 37°C. The medium was exchanged the next day to remove cellular debris and thereafter every two days during the culture period. The cells were employed for intracellular calcium measurements and a subsequent immunocytochemical characterization; supernatants were used for determination of cytokines.
Substances used for stimulation of POA primary cell cultures
CCL3/MIP-1a (>97% Purity, recombinant mouse, Catalog Number 450-MA/CF, Lot CA1209042) was purchased from R&D Systems (Minneapolis, MN, USA). CCL3 was dissolved in phosphate buffered saline (PBS, pH 7.4) at concentrations of 1 lg/ml or 1 ng/ml and added to the perfusion chamber by bolus application of 0.1 or 0.01 lg/100 ll, respectively, during a 1 min arrest of the superfusion pump (minipuls-3; Abimed Analysen-Technik, Langenfeld, Germany). The dose was chosen according to preliminary recordings from pilot studies, in which several doses were tested. A bolus control application with PBS was performed prior to stimulation with CCL3.
For the CCR1 and CCR5 blocking test, both anti-CCR5 (Monoclonal Anti-human CCR5 Antibody, Catalog number MAB181 Lot AJB11) and anti-CCR1 (Anti-mouse CCR1 Antibody, Catalog number AF5986 Lot CDQE01) were purchased from R&D Systems (Minneapolis, MN, USA). Antibodies were dissolved in phosphate buffered saline (PBS, pH 7.4) at concentrations of 25 lg/ml. The incubation with either anti-CCR1 or anti-CCR5 antibodies (2.5ug/ 100 ll) was performed either 1 h or overnight before the stimulation with CCL3.
At the end the experiment, cells were exposed to ''high potassium buffer'' (1.5 mM HEPES (Roche Diagnostics), 43 mM NaCl, 50 mM KCl, 1.5 mM MgCl 2 , 1 mM CaCl 2 (all from Merck, Darmstadt, Germany) and 10 mM D-glucose (Sigma Aldrich). This treatment served as vitality test, especially for neurons.
Fura-2 ratio imaging technique to measure intracellular Ca
2+ -levels after CCL3 cellular activation
After 5-6 days cultivation on individual CELLocate Ò glass coverslips, the cells were loaded with 2 lM fura-2-AM (MoBiTec GmbH, Göttingen, Germany) in complete medium for 45 min in a zhumidified atmosphere of 5% CO2/95% air at 37°C. For intracellular Ca 2+ -measurements, the coverslips were placed under an inverted microscope (IMT-2; Olympus Optical, Hamburg, Germany) in a specially constructed Teflon Ò culture chamber (Max-Planck Institute, Bad Nauheim, Germany) and superfused with buffer consisting of 5 mM HEPES (Roche Diagnostics), 130 mM NaCl, 5 mM KCl, 1 mM MgCl 2 , 1.25 mM CaCl 2 (Merck, Darmstadt, Germany) and 10 mM D-glucose (Sigma Aldrich). Fluorescence measurements were performed using a filterwheel-based excitation system and analyzed with MetaFluor 4.5 software (Visitron, Puchheim, Germany). After defining regions of interest for single neurons, astrocytes or microglial cells by a continuously variable aperture, the time course of emitted fluorescence (>515 nm) after alternating excitations at 340 and 380 nm, respectively, was recorded at 0.2 Hz using a Visicam 12 BIT digital CCD-camera (Visitron). The 340/380 ratios proportional to [Ca 2+ ] i were computed and data were transferred to Excel (Windows Microsoft, Munich, Germany) for further analysis.
Immunocytochemical characterization of cellular phenotypes
After the imaging experiments, the phenotypic identification of cultured neurons and glial cells was confirmed by immuno-labeling with polyclonal antisera or monoclonal antibodies directed against cell-specific marker proteins such as glial fibrillary acidic protein for astrocytes (rabbit anti GFAP; DAKO, Glostrup, Denmark), MAP2 a + b for neurons (mouse AP-20 anti MAP2 a + b ; Sigma Aldrich), ED-1 for microglial cells (mouse anti rat-ED-1; AbD Sero- From each rat pup brain, a coronal brain slice (600 lm; bregma 0.00 mm to bregma 0.60 mm) was cut with a microtome. The borders at the front and at the back of the prepared tissue slice are indicated by line drawings modified from Paxinos and Watson (2005) . The square indicates the POA tissue, which was dissected from the slice using fine eye scissors under microscopic control (ac = anterior commissure, cc = corpus cullosum, oc = optic chiasm, LV = lateral ventricle, 3 V = third ventricle). tec, Oxford, UK) and CNPase for oligodendrocytes (mouse 11-5B anti-CNP; Sigma Aldrich), Fibronectin for endothelial cells (polyclonal rabbit anti-human, A0245, Dako, Hamburg, Germany) and von Willebrand Factor for fibroblasts (polyclonal rabbit anti-human, A0082, Dako, Hamburg, Germany) (Fig. 4) . Therefore, subsequent to Ca 2+ measurements, the cells were fixed with 4% freshly prepared paraformaldehyde (Merck, Darmstadt, Germany) in 0.1 M phosphate buffer (PB), pH 7.4, for 15 min at RT. The cells were cultured and attached on the individual CELLocate Ò glass coverslips, which possess grids oriented by numbers and letters. Using these precise coordinates, it was possible determine the position of the studied cells and determine the phenotype of cells responding with measurable Ca 2+ signals, observed in the imaging procedure.
The fixed cells were rinsed three times in PBS, followed by a 60 min incubation in blocking buffer containing 10% FCS (PAA, Pasching, Austria) diluted in PBS containing 0.05% Triton X-100 (PBS-Triton) (Sigma Aldrich). The incubation with the primary antibodies (anti-GFAP 1:800, anti-MAP2 a + 2b 1:600, anti-ED1 1:2000, anti-CNPase 1:300) diluted in blocking buffer was carried out for 48 h at 4°C in a humidified chamber. Unbound antibodies were removed by three washes for 5 min each in PBS-Triton. Thereafter cells were incubated with secondary antisera such as Alexa-350-donkey anti-mouse IgG (H + L), Alexa-488-donkey anti-rabbit IgG (H + L) or anti-mouse IgG (H + L) (MoBiTec GmbH) or Cy3-goat anti-mouse IgG (H + L) (Dianova, Hamburg, Germany) at a 1:500 or 1:800 dilution in blocking buffer for 2 h at RT. After three 5 min washes in PBS-Triton, the coverslips were embedded using a glycerol/PBS solution (Citifluor LTD, London, UK). 2,3-Diamidin-2 0 -Phenylindol-dihydrochlorid (DAPI; Mobitec GmbH) was used for fluorescence staining of all cell nuclei. With an Olympus BX50 epifluorescent microscope (Olympus Optical), the cells were found according to CELLocate Ò glass coverslips coordinates, examined and photographed with the appropriate filter sets.
Measurements of TNF-a and IL-6 in supernatants of POA microcultures
After 5-6 days cultivation on CELLocate Ò glass coverslips, the POA cells were incubated with CCL3 (100 ng/ml) in complete medium for 60, or 120 min in a humidified atmosphere of 5% CO2/95% air at 37°C. After selected time intervals of incubation, the supernatants were removed from the cells, transferred and stored at À45°C for later determination of cytokines. As positive controls some samples were incubated with lipopolysaccharide (LPS, Sigma-Aldrich; 10 lg/ml).
Determination of TNF-a was performed by a bioassay based on the cytotoxic effect of TNF-a on the mouse fibrosarcoma cell line WEHI 164 subclone 13 (Espevic and Nissen-Meyer, 1986 ). The assay was performed in sterile, 96-well microtitre plates. Serial dilutions of biological samples or different concentrations of a murine TNF-a standard (code 88/532; National Institute for Biological Standards and Control, South Mimms, UK) were incubated for 24 h in wells, which had been seeded with 50,000 actinomycin D-treated WEHI cells. The number of surviving cells after 24 h was measured by use of the dimethylthiazol-diphenyl tetrazolium bromide (MTT) colorimetric assay (Holt et al., 1991) . Microculture supernatants were pre-diluted so that serial dilution of samples and standard dilution curves were parallel. The detection limit of the assay, after considering the dilution of samples for the assays, proved to be 6 pg/ml TNF-a. Determination of IL-6 was performed by a bioassay based on a dose-dependent growth stimulation of IL-6 on the B9 hybridoma cell line (Aarden et al., 1987) . The assay was performed in sterile, 96-well microtitre plates. In each well, 5000 B9 cells were incubated for 72 h with serial dilutions of biological samples or with different concentrations of human IL-6 standard (code 89/548; National Institute of Standards and Control, South Mimms, UK). According to NIBSC 1 lg of this IL-6 standard corresponds to 100,000 international units (I.U.). The number of living cells in each well was measured by use of the MTT assay (see above). The detection limits of the assay, after considering the dilution of samples for the assays, proved to be 3 international units (IU) IL-6/ml.
The levels TNF-a and IL-6, which we determined in our samples, do not reflect absolute cytokine concentrations but rather bioactivity in relation to established international standards. To confirm the specificity of the assays, we added 1 lg of a neutralizing TNF binding protein (TNFbp), a synthetic form of the type1 soluble TNF-receptor (Ross et al. 2003) or 10 ll of a neutralizing antiserum against rat-IL-6 (Harden et al. 2011) to the supernatants of some stimulated microcultures. The presence of TNFbp or IL-6-antiserum abrogated TNF-or IL-6-bioactivity in these samples completely (TNF) or almost completely (IL-6). A commercial rat IL-1b ELISA assay (900-K91; Prepro Tech, Hamburg, Germany) was employed to determine the putative release of IL-1b into the supernatants of CCL3-or LPS-stimulated POA microcultures. The sensitivity of this assay was not sufficient to detect quantifiable amounts of immunoreactive IL-1b in these samples.
Data evaluation and statistics
For data analysis, the baseline temperature prior to any injection was determined for each animal and all variations in body rectal or tail skin temperature were expressed as changes from the mean basal value (i.e., as DT, in°C). The heat loss index (HLI) was used to evaluate thermoeffector responses of the tail skin vasculature. The HLI was calculated according to the formula:
Tsk = tail skin temperature; Ta = ambient temperature and Tc = body temperature. The values of HLI will vary from 0 to 1.0, representing states of maximum vasoconstriction to maximum vasodilation, respectively (Romanovsky et al., 2002) . Results are presented as mean ± standard error of the mean (SEM), and mean baseline temperatures were not statistically different among the groups. DT and HLI responses were compared across treatments and time points analyzed by two-way ANOVA for repeated measures followed by the Bonferroni test. All data were analyzed using the Prism computer software (Graph-Pad, San Diego, CA, USA). be regarded as a strict exclusion criterion, and Dratio values are presented as means ± standard error of the mean (SEM). Levels of bioactive TNF-a and IL-6 were also shown as means ± SEM and compared by an analysis of variance (ANOVA) followed by Scheffe's post-hoc test. Because the values for cytokines are not normally distributed, a log transformation of the individual cytokine values was performed prior to the statistical calculation. The calculations were carried out using the software package StatView (Abacus Concepts, Berkeley, CA, USA).
Results
In our experimental conditions sterile saline (SAL; 500 nl) injected into AH/POA did not alter the rectal and tail skin temperature or HLI above or below baseline values for up to 6 h ( Fig. 2A) .
Conversely, the microinjection directly into the AH/POA (Fig. 2B and C) of 5, 25 or 50 pg/500 nl of CCL3 caused a dose-dependent increase of the animals' body temperature while 1 pg of CCL3 did not change the basal temperature of the rats. Five pg of CCL3 increased body temperature with a peak at 0.5 h (P < 0.05 Fig. 2A) ; 25 and 50 pg of CCL3 promoted a substantial and similar increase in body temperature, peaking 2 h after its administration (P < 0.001; Fig. 2A ) and remaining elevated until the end of the investigation period (6 h).
Because doses of 25 or 50 pg of CCL3 were equally active in increasing the rats' temperature, the lower one was chosen for the next experiment.
The increase in rectal temperature produced by the injection of 25 pg of CCL3 into the AH/POA (P < 0.01; Fig. 3A ) was accompanied by a significant reduction in the tail skin temperature (P < 0.01; Fig. 3B ). This result indicates a local (tail-skin) vasoconstriction, what can also be shown by the reduction in heat loss index (HLI) values (P < 0.01; Fig. 3C ).
CCL3 induces calcium signaling in astrocytes and neurons of POA micro-cultures
Primary rat POA microcultures after 5-6 days of in vitro differentiation contained small-sized bi-or tripolar neurons expressing microtubule-associated protein 2a + b, squamous or stellate astrocytes richly endowed with cytoskeletal GFAP, mature oligodendrocytes expressing CNPase and microglial cells staining for ED-1 (c.f. Fig. 4 ). Endothelial cells and fibroblasts proved not to be present as indicated by negative immunolabeling for fibronectin and Von Willebrand factor (data not shown). Cells of all four phenotypes were subjected to intracellular calcium imaging after CCL3 treatment.
Examples of Fura-2-loaded POA astrocytes or neurons responding to a bolus application of CCL3 with a sharp and transient increase of [Ca 2+ ] i is shown in Fig. 5 . The CCL3-induced Ca 2+ -signal occurred within seconds after CCL3 administration, while bolus injections of an equivalent volume of buffer had no effect on ] i . These numbers corresponded to 5.75% of neurons, 15.31% of astrocytes and 0% of microglial cells investigated (Fig. 6A) . It is worthwhile to mention that neurons responding to CCL3 stimulation were located in close vicinity to astrocytes. The mean strength of the CCL3-induced Ca (Fig. 6B) .
Incubation with either anti-CCR1 or anti-CCR5 antibodies blocks the CCL3-induced calcium signaling cells from POA micro-cultures
In order to investigate the effect of CCR1 or CCR5 blockade we performed two experiments, in which we employed antibodies against the respective receptors. In the first experiment we administered the antibody 1 h before the stimulation with CCL3. Nevertheless, when the POA cell culture was stimulated with a bolus injection of CCL3, calcium signals were observed even with the anti-CCR1 or anti-CCR5. We hypothesized that the duration of the pre-incubation period was not sufficient to cause the total blocking of the receptors. Therefore we performed an overnight incubation with either anti-CCR1 or anti-CCR5 on the cultures before the stimulation with CCL3 to assure that the antibody would have enough time to promote an effective binding to the receptor. Indeed, when we performed the stimulation with CCL3 after the overnight pre-incubation with anti-CCR1 we did not observe any response from 60 neurons, 74 astrocytes and 1 microglial cell (Fig. 7) . Similarly, we did not observe any signal from 77 neurons and 128 astrocytes, when the overnight pre-incubation with anti-CCR5 was realized before the stimulation with CCL3.
CCL3 does not induce formation of TNF and IL-6 by cells of POA micro-cultures
Due to the fact that a substantial number of POA astrocytes were directly responsive to CCL3-stimulation, we decided to -tracings illustrating the responsiveness of a neuron, an astrocyte and a microglia cell from POA to a bolus application of CCL3. The ratio [340/380 nm] fluorescence intensity is proportional to [Ca 2+ ] i . CCL3 was administered to the microchamber by bolus application reaching a final concentration of 100 or 10 ng/ml. Bolus application of buffer without CCL3 had no effect on [Ca 2+ ] i . Buffer containing a high concentration (50 mM) of KCl served as vitality test, especially for neurons and to some degree for astrocytes.
investigate the capacity of POA micro-cultures to produce two of those cytokines (TNF-a, IL-6) that are implicated in the manifestation of brain-controlled illness responses. In a first experiment the concentrations of bioactive cytokines (TNF-a, IL-6) were determined in supernatants of cultured POA cells incubated with CCL3 or buffer for 60 and 120 min. The results of these measurements are summarized in the Fig. 8 . Neither 60 nor 120 min after the start of incubation with CCL3 (0.01 or 0.1 lg/ml) concentrations of bioactive TNF-a or IL-6 were significantly elevated in the supernatants of POA microcultures compared to those stimulated with vehicle ( Fig. 8A and B, respectively). As a positive control some samples were stimulated with LPS instead of CCL3. Incubation of POA microcultures with LPS caused a significant increase of TNF-a at 60 min and 120 min (Fig. 8A) . Similarly, we observed a significant rise of bioactive IL-6 in the supernatant of LPS-stimulated POA-cultures at 60 min and 120 min (Fig. 8B) . These data indicate that the fever promoting effect of CCL3 is not mediated via a stimulated formation of TNF-a or IL-6 within the POA.
Discussion
We demonstrated that CCL3 not only induces an integrated febrile response when injected into the POA, but also is capable of inducing calcium signals in a population of astrocytes and neurons via CCR1 and CCR5 receptors, when administered as a bolus to neuro-glial microcultures of the rat preoptic area without changing the levels of the cytokines TNF-a and IL-6 in the supernatants of the CCL3-stimulated cells.
Some authors have shown that CCL3 is capable of increasing the rectal temperature of rats when injected into the hypothalamus or into the anterior hypothalamic preoptic area (POA) (Myers et al., 1993; Miñano et al., 1996) . Nonetheless, it remained to be determined whether the pyretic action of CCL3 would constitute an integrated fever response, which is accompanied by appropriate thermoeffector responses. The current study resolves this issue by demonstrating that the increase in core body temperature induced by CCL3 injected into the POA was accompanied by significant reduction of the heat loss index (HLI; Romanovsky et al., 2002) . The reduction of HLI was reflected by a significant decrease of tail skin temperature, indicating vasoconstriction of the local (tail) vascular bed aimed to retain heat, which is a characteristic feature of the febrile response (O'Leary et al., 1985) . The rat's tail serves as a variable heat exchanger (O'Leary et al., 1985; Gordon, 2002), since its blood flow is regulated by the activity of sympathetic vasoconstrictor nerves, specifically controlled by neurons of the raphé magnus/pallidus nuclei (Blessing and Nalivaiko, 2001 ). Thus, it seems that CCL3, injected into the POA, evokes a concerted thermoregulatory response by stimulating vasoconstriction of cutaneous vessels via an efferent thermoregulatory pathway, in which the reduced efficacy of the tail skin to dissipate body heat collaborates with the progress of fever. Astrocytes represent the main cellular phenotype, which was responsive to CCL3 in the POA cell culture. It is worthwhile to note that just about 15% of all investigated astrocytes responded to CCL3, suggesting that only a subpopulation of astrocytes presents specific receptors for the CCL3 coupling. Interestingly, there is a current debate about the essential characteristics of an astrocyte. For example, the ependymoglia often exhibit some astrocyte-like features (Kettenmann and Ransom, 1988) but are not habitually considered as astrocytes. Conversely, the convergence of anatomical phenotype between radial glia and the elongated radially oriented astrocytes present in areas such as the supraoptic nucleus (Bonfanti et al., 1993) and their capacity to differentiate into astrocytes, have contributed to suggestions that radial glia be classified more broadly as astrocytes (Kimelberg, 2010) . It is probable that future classifications of astrocytes will recognize many cells with a continuum of functions, phenotypes and cellular origins under the broad descriptor ''astrocyte'' rather than placing an emphasis on a few discrete categories.
We also observed a small population of neurons in the POA cell culture, which directly responded to CCL3 stimulation increasing intracellular calcium. In view of that, we can hypothesize a direct activation of neurons, which might belong to thermoregulatory relevant structures within the POA or, at least project to those, and thus contribute to the generation of fever and other brain-controlled signs of illness (Romanovsky et al., 2009 , Dantzer, 2009 . Nonetheless, it is essential to mention that some neurons were placed close to one or more astrocytes. A good cell selection for the intracellular Ca 2+ measurements is based on cellular differentiation, cell types present in the microscopic field and spacing between cells. It is important to avoid cells with microscopically visible intercellular contact zones. Nevertheless, sometimes the cells are still very close to each other. Neurons generally need astrocytic feeder cells in their vicinity, and astrocytes tend to cluster (Ott et al., 2010 (Ott et al., , 2012 . Therefore, we cannot exclude the possibility that a part or even all of the CCL3-responsive neurons might have been indirectly activated by CCL3 via the astrocytes in their vicinity. For instance, it is possible to imagine either that those neurons express CCR1 or CCR5 receptors (Galasso et al., 1998) , or the response results from CCL3 stimulated astrocytes releasing some signals to neurons. In fact, astrocytes respond to neuronal activity or neurotransmitters, through the activation of several receptors, and can release the gliotransmitters such as ATP, D-serine, and glutamate, which act on neurons (Halassa and Haydon, 2010) . In this context, it was shown before that either CCL3 or CCL4 do not depend on the synthesis of new mediators to evoke fever in rats, which indicates that those chemokines act directly on the POA area cells (Tavares and Miñano, 2004; Soares et al., 2006) . Furthermore, Machado et al. (2007) demonstrated that the injection of Met-RANTES, a CCR1 and CCR5 receptors antagonist, inhibited LPSinduced fever indicating that receptors are involved in this response. The calcium imaging indicates that CCL3 can activate POA primary cultured cells. Intra POA injection induces fever response in rats. As mentioned before, both astrocytes and neurons express CCR1 and CCR5 receptors (Bajetto et al., 1999; Galasso et al., 1998) . Anyhow, either the direct stimulation of neurons or astrocyte-mediated neuronal stimulation can explain the described PG-independent pyrogenic effect of CCL3 (Soares et al., 2006) . Taken together, these results suggest that CCL3 could act directly on POA cells, via CCR1 or CCR5 to induce fever. Nevertheless this issue needs further experimental clarification. Surprisingly, we did not observe CCL3-induced Ca 2+ signaling in microglial cells. Nonetheless, the participation of microglia on the CCL3-induced fever cannot be ruled out. The surgery for placing the guide cannula could induce a microglial activation which would result in a sensitized pro-inflammatory response to a pyrogenic stimulus. For instance, it was described that the spinal cord injury induced the expression of CCL1 at the site of injury. On the other hand no CCR1-immunoreactivity was found in sham controls (Knerlich-Lukoschus et al., 2011) . In the light of this information we can imagine that the surgery for placing the guide cannula could have a functional impact on the CCL3 injection. Indeed, this kind of stab trauma has recently been shown to activate inflammatory transcription factors around the injection site of an implanted cannula (Damm et al. 2013 ) and thus could have influenced the responsiveness of microglial cells in this area. Further studies are planned to investigate the role of microglia on CCL-3 induced fever under this experimental condition. Boddeke et al. (1999) showed that the cells from the POA responsive to RANTES did not respond to MCP-1 and vice versa. This implies that the MCP-1 activates CCR2 while RANTES stimulates CCR1 and/or CCR5 in distinct subpopulations of microglia. Corroborating those data, Tavares and Miñano (2004) had shown that the microinjection of neutralizing antibody against the CCR5 receptor in the POA does not affect the effects on body temperature induced by CCL4. However, pre-treatment with the same dose of anti-CCR5 suppressed the febrile response induced by RANTES administered to the same location. Thus, the authors demonstrated that hypothalamic CCR5 is functionally involved in fever induced by RANTES, but not by CCL4. The latter is suggested to stimulate the CCR1 receptors. Although these two peptides are structurally and functionally similar, each of them has distinct characteristics, which enables them to independently regulate specific aspects of the inflammatory response of the host.
The overnight incubation with either anti-CCR1 or anti-CCR5 antibody was effective in blocking the Ca++ mobilization in POA primary cell cultures induced by CCL3. It indicates that, under this experimental condition, those receptors present a key role on the CCL3-induced cell activation. Nevertheless, the complete blockade of the action of CCL3 by each of the applied antibodies is surprising and makes it quite difficult to discuss the effects of both antibodies on the stimulation of each receptor separately. Nevertheless, other authors have found similar effects in different research fields. For instance, Oba et al. (2005) have shown that by blocking either CCR1 or CCR5 the CCL3-induced osteoclast formation and myeloma cells adhesion to stromal cells are both inhibited. It is worthwhile to mention that when the authors of this study tried to combine both antibodies (anti-CCR1 + anti-CCR5) the inhibition was not different from the isolated antibody treatment. Moreover, it is worthwhile to mention that a given antibody not only can have antagonist-like action, but may also facilitate receptor internalization. Therefore the 1-h incubation was probably not sufficient for this process as reported in some studies showing the effects of treatment with antibodies against CCR1 and CCR5 on synaptosomes (Musante et al., 2008; Di Prisco et al., 2012) . This observation suggests that both receptors have a functional role in mediating CCL3 actions.
In addition to the transient increase of [Ca 2+ ] i , we showed for the first time that CCL3 does not cause an increase of TNF-a or IL-6 in the POA microculture supernatants. Since fever induced by TNF-a or IL-6 depends on PGE 2 synthesis (Souza et al., 2002; Rothwell et al., 1991; Hamzic et al., 2013) our present results endorse our previous finding that CCL3 does not require eicosanoid synthesis to evoke a febrile response (Soares et al., 2006 ).
In conclusion the present study shows for the first time that CCL-3 injected directly into the rat POA, evoked an integrated febrile response. In parallel this chemokine induces Ca ++ signaling in astrocytes and neurons via both CCR1 and CCR5 receptors when applied to POA microcultures without stimulating the synthesis of TNF-a and IL-6. It is a possibility that CCL3-induced fever may occur via CCR1 and CCR5 receptors stimulation of astrocytes and neurons from POA.
